Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines
Rating :
Not applicable
Economic aspects
All age groups
Rotavirus
Pneumococcal disease
Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus
Rating :
Critically low
Efficacy/effectiveness
Newborn (0-1 years)
Children (2-9 years)
Adolescents (10-18 years)
Cholera
Rotavirus
Outstanding challenges for rotavirus vaccine introduction in low-income countries - a systematic review
Rating :
Not applicable
Economic aspects
Efficacy/effectiveness
Logistics
All age groups
Rotavirus
Rotavirus vaccine RIX4414 (Rotarix™): A pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries
Rating :
Not applicable
Economic aspects
All age groups
Rotavirus
Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: A systematic review of the experience in industrialized countries
Rating :
Critically low
Efficacy/effectiveness
All age groups
Rotavirus